Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Amneal Forecasts Fiscal Year 2024 Revenues Of $2.55B-$2.65B Versus Consensus Of $2.58B And Adjusted EPS Of $$0.53-$0.63 Versus Consensus Of $0.59

Author: Benzinga Newsdesk | March 01, 2024 07:06am

Posted In: AMRX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist